Cargando…

Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion

The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Katsuya, Nishiuchi, Takumi, Tange, Shoichiro, Suzuki, Yoshinori, Yano, Seiji, Terashima, Minoru, Suzuki, Takeshi, Matsumoto, Kunio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541533/
https://www.ncbi.nlm.nih.gov/pubmed/33028834
http://dx.doi.org/10.1038/s41598-020-72448-y
_version_ 1783591412186480640
author Sakai, Katsuya
Nishiuchi, Takumi
Tange, Shoichiro
Suzuki, Yoshinori
Yano, Seiji
Terashima, Minoru
Suzuki, Takeshi
Matsumoto, Kunio
author_facet Sakai, Katsuya
Nishiuchi, Takumi
Tange, Shoichiro
Suzuki, Yoshinori
Yano, Seiji
Terashima, Minoru
Suzuki, Takeshi
Matsumoto, Kunio
author_sort Sakai, Katsuya
collection PubMed
description The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and the gene expression of MMP-2 was correlated with the invasive phenotype. The MMP-2 gene expression was regulated by DNA and histone methylation around the transcription start site, implicating the involvement of the polycomb repressive complex (PRC). Knockdown of PRC component chromobox 6 (CBX6) promoted MMP-2 expression and invasion of mesothelioma cells. Transcriptome analysis suggested that CBX6 regulates sets of genes involved in cancer cell migration and metastasis. In invasive but not non-invasive cells, CBX6 was constantly unstable owing to ubiquitination and protein degradation. In human tissues, CBX6 localized in the nuclei of normal mesothelium and benign mesothelioma, but the nuclear staining of CBX6 was lost in malignant mesothelioma. These results suggest involvement of proteasomal degradation of CBX6 in mesothelioma progression.
format Online
Article
Text
id pubmed-7541533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75415332020-10-08 Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion Sakai, Katsuya Nishiuchi, Takumi Tange, Shoichiro Suzuki, Yoshinori Yano, Seiji Terashima, Minoru Suzuki, Takeshi Matsumoto, Kunio Sci Rep Article The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and the gene expression of MMP-2 was correlated with the invasive phenotype. The MMP-2 gene expression was regulated by DNA and histone methylation around the transcription start site, implicating the involvement of the polycomb repressive complex (PRC). Knockdown of PRC component chromobox 6 (CBX6) promoted MMP-2 expression and invasion of mesothelioma cells. Transcriptome analysis suggested that CBX6 regulates sets of genes involved in cancer cell migration and metastasis. In invasive but not non-invasive cells, CBX6 was constantly unstable owing to ubiquitination and protein degradation. In human tissues, CBX6 localized in the nuclei of normal mesothelium and benign mesothelioma, but the nuclear staining of CBX6 was lost in malignant mesothelioma. These results suggest involvement of proteasomal degradation of CBX6 in mesothelioma progression. Nature Publishing Group UK 2020-10-07 /pmc/articles/PMC7541533/ /pubmed/33028834 http://dx.doi.org/10.1038/s41598-020-72448-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sakai, Katsuya
Nishiuchi, Takumi
Tange, Shoichiro
Suzuki, Yoshinori
Yano, Seiji
Terashima, Minoru
Suzuki, Takeshi
Matsumoto, Kunio
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title_full Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title_fullStr Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title_full_unstemmed Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title_short Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
title_sort proteasomal degradation of polycomb-group protein cbx6 confers mmp-2 expression essential for mesothelioma invasion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541533/
https://www.ncbi.nlm.nih.gov/pubmed/33028834
http://dx.doi.org/10.1038/s41598-020-72448-y
work_keys_str_mv AT sakaikatsuya proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT nishiuchitakumi proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT tangeshoichiro proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT suzukiyoshinori proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT yanoseiji proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT terashimaminoru proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT suzukitakeshi proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion
AT matsumotokunio proteasomaldegradationofpolycombgroupproteincbx6confersmmp2expressionessentialformesotheliomainvasion